BillionaireNet
Abdalá
Fernando Espinosa Abdalá
Rank #2366
MEXICOHealthcarePharmaceuticals

Fernando Espinosa Abdalá

Net Worth
$1.575B
0% (24h)
Fernando Espinosa Abdalá, a Mexican billionaire, built his fortune primarily through the pharmaceuticals industry. Born in 1950, he is 75 years old as of December 17, 2025. Espinosa Abdalá's wealth stems from his former pharmaceutical company, Rimsa, which was sold to Teva Pharmaceutical Industries for $2.3 billion in 2016. He was the operational president of Rimsa before the sale. As of December 16, 2025, his net worth is estimated to be $1.57 billion, and he holds the 2363rd position in the world. He resides in Mexico City.

The Full Dossier

Early Life

Fernando Espinosa Abdalá was born in 1950. His father founded a pharmaceutical distribution company in 1970, which later expanded into manufacturing. This laid the foundation for the family's future wealth.

Rise to Success

Espinosa Abdalá's career is closely tied to the pharmaceutical company Rimsa. He served as the operational president of the company. Rimsa became a prominent pharmaceutical manufacturing and distribution company in Mexico, with a diverse range of patent-protected products. The significant turning point in Espinosa Abdalá's business journey came in 2016 when Rimsa was sold to Teva Pharmaceutical Industries for $2.3 billion.

Key Business Strategies

Espinosa Abdalá's success can be attributed to the strategic development and expansion of Rimsa, a key player in the Mexican pharmaceutical market. Rimsa's focus on patent-protected products and innovative fixed-dose combination products played a crucial role in its market position and eventual sale.

Philanthropy

Information on his specific philanthropic activities is limited due to his preference for a low public profile.

Career Timeline

2016

Sale of Rimsa

Rimsa, led by Fernando as operational president, was sold to Teva Pharmaceutical Industries for $2.3 billion.

1970

Rimsa Founded

The foundation of the family's wealth began with the founding of a pharmaceutical distribution company, which later expanded into manufacturing.

Philanthropic Impact

UnknownUndisclosed

Unknown

Specific philanthropic activities are not publicly available.

Wealth Trajectory